Because of these aforementioned observations of the inflammasome, a number of recent publications have implicated the activation of the NLRP3 inflammasome to a variety of metabolic diseases including obesity, atherosclerosis and type 2 diabetes [76]. This evidence concerns the gene NLRP3 and obesity disorder.